Caricamento...
Financial Evaluation of Kidney Transplant With Hepatitis C Viremic Donors to Uninfected Recipients
Kidney transplantation with hepatitis C viremic (dHCV+) donors appears safe for recipients without HCV when accompanied by direct acting antiviral (DAA) treatment. However, US programs have been reluctant to embrace this approach due to concern about insurance coverage. While the cost of DAA treatme...
Salvato in:
| Pubblicato in: | Transplant Direct |
|---|---|
| Autori principali: | , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Lippincott Williams & Wilkins
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7665247/ https://ncbi.nlm.nih.gov/pubmed/33204825 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000001056 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|